Tranche Update on Kyung Dong Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 10, 2021.
May 26, 2021 at 02:02 am EDT
Share
From May 10, 2021 to May 26, 2021, the company has repurchased 250,000 shares, representing 0.9% for KRW 2,671.22 million. With this, the company has completed the repurchase of 250,000 shares, representing 0.9% for KRW 2,671.22 million under the buyback announced on May 10, 2021.
KYUNG DONG PHARMACEUTICAL CO.,LTD. is a Korea-based company engaged in the manufacture and marketing of pharmaceutical products. The Companyâs products include liver therapies, gastrointestinal drugs, antimigraine drugs, antiviral, anti-obesity medications, antibacterial drugs, antidiabetic drugs, antifungal, allergy medications, antispasmodics, antihistamines, vitamins, as well as drugs for osteoporosis, cardiovascular, muscle relaxant, neuropathic and other diseases. It also provides various over-the-counter (OTC) drugs, such as anti-inflammatory medicines, antiviral drugs, antihistamine drugs, gastrointestinal drugs and others. In addition, the Company engages in the leasing of real estate, and distribution of snowboards and health functional food.
KYUNG DONG PHARMACEUTICAL CO., LTD. 